Related Experiment Video
Updated: Apr 17, 2026
10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
3.0K
14q32-encoded microRNAs mediate an oligometastatic phenotype
Abhineet Uppal1, Sean C Wightman1, Stephen Mallon2,3
1Department of Surgery, The University of Chicago, Chicago, IL 60637, USA.
Oncotarget
|February 18, 2015
Summary
Oligometastasis, a curable form of cancer spread, involves microRNAs that suppress tumor cell movement and invasion. These microRNAs offer potential for new treatments targeting limited metastatic disease.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Oligometastasis represents a unique clinical state with limited, potentially curable metastases.
- Understanding the molecular drivers of oligometastasis is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate microRNAs over-expressed in oligometastasis.
- To identify the pathways regulated by these microRNAs.
- To explore the therapeutic potential of these microRNAs in metastatic cancer.
Main Methods:
- Analysis of microRNA expression in clinical oligometastasis samples.
- Bioinformatic pathway analysis to identify targeted pathways.
- In vivo validation using a breast cancer lung colonization animal model.
Main Results:
- Over-expressed microRNAs in oligometastasis suppress cellular adhesion, invasion, and motility pathways.
- miR-127-5p, miR-544a, and miR-655-3p from the 14q32 cluster co-regulate metastatic pathways.
- These microRNAs inhibit metastasis development and target genes like TGFBR2 and ROCK2.
Conclusions:
- Specific microRNAs play a key role in the oligometastatic phenotype by suppressing invasion and motility.
- These microRNAs represent potential therapeutic targets for curable metastatic disease.
- Further understanding of microRNA roles can improve identification and treatment of oligometastatic patients.
Related Concept Videos
01:22MicroRNAs
4.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
01:22MicroRNAs
24.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.9K
01:22MicroRNAs
12.1K
12.1K
02:39lncRNA - Long Non-coding RNAs
10.2K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K